Steven B. Ratoff

Steven B. Ratoff discloses dealings in 3 companies, chiefly Novadel Pharma Inc, Eagle Pharmaceuticals, Inc. and Raptor Pharmaceutical Corp. Between 19 April 2006 and 8 April 2021, the trades on record add up to 27 filings.

In open-market terms, that means 16 purchases worth €646k on one side and 2 sales worth €706k on the other. The net balance comes to €59k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 6 option exercises.

The median purchase comes to €21k.

Most recently, on 12 April 2021, the filings show an option exercise worth €17k in Eagle Pharmaceuticals, Inc. The most recent open-market purchase was published on 14 December 2016, 3,601 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.